Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
Phase 3
- Conditions
- Anxiety Disorder Generalized
- Interventions
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- ChemRar Research and Development Institute, LLC
- Target Recruit Count
- 200
- Registration Number
- NCT04598867
А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- ChemRar Research and Development Institute, LLC
- Target Recruit Count
- 129
- Registration Number
- NCT04524975
- Locations
- 🇷🇺
Clinical Center LLC "Center for Psychotherapy "Support", Stavropol, Stavropol Region, Russian Federation
🇷🇺"Research Center for Mental Health" Scientific Institution, Moscow, Russian Federation
🇷🇺Clinical Center LLC "University Headache Clinic", Moscow, Russian Federation
News
No news found